论文部分内容阅读
①目的了解肝癌病人癌与癌旁组织中雄激素受体（ＡＲ）的改变。②方法用葡聚糖包裹活性炭饱和吸附法（ＤＣＣ法）检测２１例肝细胞癌（ＨＣＣ）癌组织和癌旁组织中ＡＲ，并与７例男性肝硬变病人肝组织中的ＡＲ进行了比较。③结果癌组织中ＡＲ的含量显著高于癌旁组织（ｔ＝２．７９３，Ｐ＜０．０１）及硬变肝组织（ｔ＝２．３２３，Ｐ＜０．０５）。④结论ＡＲ的增加与肝细胞的恶变有关，从而为ＨＣＣ的内分泌治疗提供分子生物学依据。
Objective To understand the changes of androgen receptor (AR) in cancer and adjacent tissues of patients with hepatocellular carcinoma. 2Methods AR was detected with dextran-encapsulated activated carbon saturated adsorption (DCC) in 21 cases of hepatocellular carcinoma (HCC) cancer tissues and paracancerous tissues, and compared with AR in liver tissues of 7 male cirrhosis patients. . 3 Results The content of AR in cancer tissues was significantly higher than that in adjacent tissues (t=2.793, P<0.01) and in hardened liver tissues (t=2.323, P<0.05). 4 Conclusion The increase of AR is related to the malignant transformation of hepatocytes, thus providing a molecular biological basis for the endocrine therapy of HCC.